310 related articles for article (PubMed ID: 24084477)
1. Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials.
Carvalho AF; Hyphantis T; Sales PM; Soeiro-de-Souza MG; Macêdo DS; Cha DS; McIntyre RS; Pavlidis N
Cancer Treat Rev; 2014 Apr; 40(3):349-55. PubMed ID: 24084477
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
[TBL] [Abstract][Full Text] [Related]
3. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
[TBL] [Abstract][Full Text] [Related]
5. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of St. John's wort for major depressive disorder.
Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S
Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of depression in women with breast cancer: a systematic review.
Toftegård Andersen L; Voigt Hansen M; Rosenberg J; Gögenur I
Breast Cancer Res Treat; 2013 Oct; 141(3):325-30. PubMed ID: 24077731
[TBL] [Abstract][Full Text] [Related]
8. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
Jakobsen JC
Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.
Lee Y; Rosenblat JD; Lee J; Carmona NE; Subramaniapillai M; Shekotikhina M; Mansur RB; Brietzke E; Lee JH; Ho RC; Yim SJ; McIntyre RS
J Affect Disord; 2018 Feb; 227():406-415. PubMed ID: 29154157
[TBL] [Abstract][Full Text] [Related]
10. Differing antidepressant maintenance methodologies.
Safer DJ
Contemp Clin Trials; 2017 Oct; 61():87-95. PubMed ID: 28739537
[TBL] [Abstract][Full Text] [Related]
11. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder.
McIntyre RS; Suppes T; Tandon R; Ostacher M
J Clin Psychiatry; 2017 Jun; 78(6):703-713. PubMed ID: 28682531
[TBL] [Abstract][Full Text] [Related]
12. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice.
van der Lem R; van der Wee NJ; van Veen T; Zitman FG
Psychother Psychosom; 2012; 81(4):226-34. PubMed ID: 22584117
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder.
Cameron IM; Reid IC; MacGillivray SA
J Affect Disord; 2014 Sep; 166():48-58. PubMed ID: 25012410
[TBL] [Abstract][Full Text] [Related]
14. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of pharmacological or psychological interventions for smoking cessation in smokers with major depression or depressive symptoms: A systematic review of the literature.
Aldi GA; Bertoli G; Ferraro F; Pezzuto A; Cosci F
Subst Abus; 2018; 39(3):289-306. PubMed ID: 29436984
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysis.
Krause M; Gutsmiedl K; Bighelli I; Schneider-Thoma J; Chaimani A; Leucht S
Eur Neuropsychopharmacol; 2019 Sep; 29(9):1003-1022. PubMed ID: 31327506
[TBL] [Abstract][Full Text] [Related]
17. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
Iovieno N; Papakostas GI
J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
[TBL] [Abstract][Full Text] [Related]
18. Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder: A Systematic Review and Meta-analysis.
Guidi J; Fava GA
JAMA Psychiatry; 2021 Mar; 78(3):261-269. PubMed ID: 33237285
[TBL] [Abstract][Full Text] [Related]
19. Are studies of psychotherapies for depression more or less generalizable than studies of antidepressants?
Lorenzo-Luaces L; Zimmerman M; Cuijpers P
J Affect Disord; 2018 Jul; 234():8-13. PubMed ID: 29522947
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.
Reddy S; Kane C; Pitrosky B; Musgnung J; Ninan PT; Guico-Pabia CJ
Curr Med Res Opin; 2010 Jan; 26(1):139-50. PubMed ID: 19919295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
